Anugraha Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 0.25 M
as on 20-12-2024
- Company Age 39 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -72.64%
(FY 2019)
- Profit 87.32%
(FY 2019)
- Ebitda 89.14%
(FY 2019)
- Net Worth -2.28%
(FY 2019)
- Total Assets 19.88%
(FY 2019)
About Anugraha Pharma
The Corporate was formerly known as Anugraha Ayurvedic Pharmaceuticals Pvt Ltd. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Jeothi and Nikhil Pradeep serve as directors at the Company.
- CIN/LLPIN
U24231KL1985PTC004266
- Company No.
004266
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anugraha Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Jeothi  | Managing Director | 26-Jul-1985 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Pradeep | Director | 17-Sep-2014 | Current |
Financial Performance of Anugraha Pharma.
Anugraha Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 72.64% decrease. The company also saw a substantial improvement in profitability, with a 87.32% increase in profit. The company's net worth dipped by a decrease of 2.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anugraha Pharma?
In 2019, Anugraha Pharma had a promoter holding of 4.00% and a public holding of 96.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vasudeva Vilasam Herbal Remedies Private LimitedActive 27 years 3 monthsPradeep Jeothi and Nikhil Pradeep are mutual person
Vasudeva Vilasam Aryavaidyasala Private LimitedActive 17 years 7 monthsPradeep Jeothi and Nikhil Pradeep are mutual person
- Aanantapadmanabha Nidhi LimitedActive 5 years 7 months
Pradeep Jeothi and Nikhil Pradeep are mutual person
- Peekon Advisors Private LimitedActive 9 years 8 months
Pradeep Jeothi and Nikhil Pradeep are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anugraha Pharma?
Unlock and access historical data on people associated with Anugraha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anugraha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anugraha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
